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ABSTRACT
Background: Breastfeeding is associated with long-term health benefits, such as a 
lower incidence of childhood infections, asthma, obesity and autoimmune disorders. 
However, little is known regarding how the maternal and neonatal immune systems 
interact after parturition when the neonate receives nutrition from maternal breast 
milk.
Methods: We undertook a comparative analysis of immune repertoire and function at 
birth and 3 weeks of age in a cohort of 38 term neonates born by caesarean section 
grouped according to feeding method (breast milk versus formula). We used flow cy-
tometry to study the immune phenotype in neonatal and maternal blood samples and 
mixed lymphocyte reactions to establish the proliferation response of neonatal versus 
maternal lymphocytes and vice versa. The microbiome of neonatal stool samples was 
also investigated using 16S rRNA sequencing.
Results: We show that the proportion of regulatory T cells (Tregs) increases in this 
period and is nearly twofold higher in exclusively breastfed neonates compared with 
those who received formula milk only. Moreover, breastfed neonates show a spe-
cific and Treg-dependent reduction in proliferative T-cell responses to non-inherited 
maternal antigens (NIMA), associated with a reduction in inflammatory cytokine pro-
duction. We also observed the enrichment of short chain fatty acid producing taxa 
(Veillonella and Gemella) in stool samples of exclusively breastfed neonates.
Conclusions: These data indicate that exposure of the neonate to maternal cells 
through breastfeeding acts to drive the maturation of Tregs and ‘tolerizes’ the neo-
nate towards NIMA.
K E Y W O R D S
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1  |  INTRODUC TION
Exposure and adaptation to extra-uterine life represents a substan-
tial homeostatic challenge for the cardiovascular and respiratory 
as well as the immune systems of neonates. Paramount amongst 
these are modifications within immune function which must facili-
tate acquisition of a symbiotic microbiome whilst protecting against 
pathogen challenge. Infection is a significant cause of morbidity and 
mortality in neonates1-3 but current understanding of the functional 
capacity of the neonatal immune system in the first few weeks of 
life remains limited. Substantial differences are observed between 
neonatal and adult immune function.4,5 For example, CXCL8 (IL-8) is 
the major effector chemokine of neonatal T cells whilst production 
of IFN-γ is markedly suppressed and a reduction in natural killer (NK) 
cell numbers is observed.4,6
Elegant multi-dimensional analyses have revealed a significant 
increase or decrease in various immune cell subsets as well as plasma 
protein levels within the first week of life, initiating a stereotypic 
immune differentiation pathway. This profile is seen in both preterm 
and term infants and as such appears to represent a response to mul-
tiple environmental cues, predominantly microbial, that are received 
after birth.7 Dynamic alterations in the interferon and complement 
pathways, as well as neutrophil-associated signalling, are particularly 
prominent.8 However, less is known regarding neonatal immune 
function and the potential impact of nutritional intake on immune 
homeostasis.
An important consideration in relation to neonatal immune func-
tion is the threshold of immune response versus tolerance in the 
early postnatal period. A range of factors act to limit alloreactive 
immune responses during pregnancy and avoid immunological re-
jection of the foetus. This includes an increase in both maternal and 
foetal-derived regulatory T cells (Tregs)5,9 together with preferen-
tial differentiation of foetal CD4+ cells towards Treg phenotype10 
mediated through increased ‘tolerogenic’ dendritic cell activity.11 It 
is likely that this balance towards relative immune suppression con-
tinues into neonatal life but the profile of this, and its relative de-
pendence on the postnatal environment, as well as the presence of 
non-inherited maternal antigens (NIMA) remain unclear.
The perinatal establishment of the gut microbiome is likely to 
be a dominant regulator of neonatal immune development. Indeed, 
colonization with specific commensal bacteria can enhance the 
development of Treg responses,12 whilst dysbiosis disturbs stereo-
typic immune development and promotes T-cell activation.7 Vertical 
transmission of maternal microbiota is the initial, and potentially 
most important, determinant of the neonatal microbiome. In this 
regard, it is notable that the mode of delivery is a critical factor and 
its influence on childhood microbiome extends for at least 7 years.13 
The influence of microbiome composition on long-term health out-
comes is an area of considerable interest and atypical colonization 
has been associated with a range of conditions including impaired 
immune function and increased risk of allergy.14
The importance of nutrition as a determinant of the profile of 
neonatal immunity has been poorly investigated.15,16 The natural 
nutrition for neonates is from breast milk which contains a range of 
complex nutrients as well as antimicrobial proteins. Breast milk also 
contains bacteria and maternal cells, and as such, it is not surprising 
that exposure to either breast milk or formula milk significantly influ-
ences the composition of the gut microbiome.17
G R A P H I C A L  A B S T R A C T
• The proportion of Tregs is nearly twofold higher in exclusively breastfed neonates compared with those who received formula milk only.
• Breastfed neonates show a specific and Treg-dependent reduction in proliferative T-cell responses to non-inherited maternal antigens.
• Short chain fatty acid producing taxa (Veillonella and Gemella) are enriched in stool samples of exclusively breastfed neonates.
Abbreviations: PBMC, peripheral blood mononuclear cell; Treg, regulatory T cell.
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Differential microbiome composition is likely to act as an indirect 
influence on how nutrition can modify the neonatal immune profile 
but there may also be a direct effect from exposure to maternal cells 
and antigenic proteins within milk. We analysed how immune pheno-
type and function evolve between birth and 3 weeks of age in a cohort 
of healthy neonates born by caesarean section. This timeframe was 
chosen to allow for changes related to the type of milk received to 
occur but to avoid potential confounding effects of immunization and 
acquired infections. We designed mixed lymphocyte reactions that al-
lowed us to study the interaction of the maternal and neonatal immune 
systems. Our aim was to determine prospective changes in the neo-
natal adaptive immune response in relation to source of nutrition and 
neonatal gut microbiome with a specific focus on regulatory T cells.
2  |  METHODS
A total of 38 healthy pregnant women who were planned to deliver 
electively at gestational term by caesarean section were sampled in 
our study at Birmingham Women's Hospital, UK. Peripheral blood 
samples were collected prior to the caesarean section and all women 
were not in labour and had intact membranes. Sixteen out of 38 ba-
bies (42%) were exclusively breastfed for the duration of the study, 
whilst 9 babies received mixed feeding and 13 babies were exclu-
sively formula-fed. Further characteristics of the neonatal popula-
tion are male/female: 17/21, gestational age: 39 [39–39] weeks and 
birth weight: 3530 [3298–3733] g.
Cord blood samples were taken immediately after delivery. A 
peripheral blood sample (up to 2 mL) was taken from the neonate 
at 3 weeks of age. In addition to the blood samples, a neonatal stool 
sample was collected at birth and at 3 weeks of age from 29 of the 
recruited neonates. Exclusion criteria included multiple pregnancy, 
sepsis risk factors (especially maternal fever or chorioamnionitis), 
Group B Streptococcus positivity in the current pregnancy, genetic 
conditions of the foetus or the mother, maternal HIV, maternal tu-
berculosis, maternal new-onset viral infection, maternal hyperten-
sive disorder, maternal endocrine condition or diabetes, maternal 
asthma and maternal autoimmune conditions, as well as maternal 
medication other than pregnancy supplements. Peripheral blood 
samples were also collected from 13 healthy, non-pregnant adults 
(male/female: 6/7) who were age-matched to the pregnant women.
Informed written consent was obtained from all pregnant women 
and healthy volunteers. The study was reviewed and approved by 
the East Midlands—Nottingham 2 NHS Research Ethics Committee 
(reference 16/EM/0379).
2.1  |  Mononuclear cell isolation from 
blood samples
Blood samples were collected into EDTA anticoagulated tubes. 
Peripheral blood mononuclear cells (PBMCs) were isolated by 
density centrifugation using Lymphoprep (Stemcell Technologies, 
Seattle, WA, USA). PBMCs were washed with RPMI-1640 medium 
(Sigma-Aldrich, St. Louis, MO, USA) and used either directly or cryo-
preserved in foetal bovine serum containing 10% dimethyl sulphox-
ide (DMSO) (Sigma-Aldrich). After thawing, cells were washed with 
RPMI and re-suspended in enriched media (RPMI-1640 + foetal bo-
vine serum 10% + 2 mM glutamine). Viability of thawed cells was 
consistently >90% as assessed by methylene blue exclusion. For im-
munophenotyping, a small portion of cells was frozen from all blood 
samples and samples were processed in batches after thawing. For 
mixed lymphocyte reactions, cord blood and neonatal blood samples 
at 3 weeks of age were used directly. Pregnant and non-pregnant 
adult samples were split at the time of sampling and one part of the 
samples was used directly with cord blood, whilst the other part 
was frozen and retained to be used 3 weeks later with the neonatal 
blood.
2.2  |  Immunophenotyping
Mononuclear cells were prepared as described above for two im-
munophenotyping panels. Panel 1 was designed to study intracel-
lular cytokine production following stimulation, using unstimulated 
cells as controls. Cells were stained with FITC-conjugated CD107a 
(Biolegend, San Diego, CA, USA) at the time of stimulation, as this 
marker is only detectable on the cell surface upon degranulation 
in conjunction with stimulation.18 Stimulation was performed with 
phorbol myristate acetate (PMA, 50 ng/mL, Sigma-Aldrich) and iono-
mycin (1 μg/mL, Sigma-Aldrich) for a total of 3.5 hours at 37 degrees 
centigrade. After 30 minutes, 1.25 μg/mL of monensin (Sigma-
Aldrich) was added to stimulated cells for the remaining 3 hours. 
Cells were then washed with phosphate-buffered saline (PBS, Sigma-
Aldrich) and re-suspended in MACS buffer. Cell surface staining was 
performed for 30 minutes on ice in the dark as follows: BV510-
conjugated CD4, PerCP-Cy5.5-conjugated CD8, ECD-conjugated 
CD14/CD19/CD56, APC-Cy7-conjugated CD3 (all from Biolegend) 
and Live/Dead (red, 488 nm, Invitrogen, Carlsbad, CA, USA). After 
washing, cells were fixed with fixation/permeabilization solution 
(eBioscience, San Diego, CA, USA) for 30 minutes at room temper-
ature in the dark. Cells were washed with permeabilization buffer 
(eBioscience). Following centrifugation and re-suspension in MACS 
buffer, the following intracellular dyes were added for 30 minutes 
at room temperature in the dark: PE-Cy7-conjugated IL-6, AF700-
conjugated IFN-γ, AF647-conjugated IL-4, BV421-conjugated IL-17A 
and PE-conjugated IL-8 (all from Biolegend). Cells were then washed 
and run on an LSRII flow cytometer equipped with blue, red and vio-
let lasers (BD Biosciences, San Jose, CA, USA). The staining proce-
dure was identical for unstimulated cells. At least 50,000 cells were 
recorded per sample. Unstained and single-stained samples were 
used as compensation controls in flow cytometry experiments. All 
antibodies and dyes were used in concentrations recommended by 
the relevant manufacturer.
Panel 2 assessed the immunophenotype of cells without mi-
togenic stimulation. Cells were surface stained in MACS buffer 
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with PE-Cy7-conjugated HLA-DR, BV510-conjugated CD4, PerCP-
conjugated CD69, ECD-conjugated CD14/CD19/CD56, AF700-
conjugated CD45RA, APC-Cy7-conjugated CD3, BV421-conjugated 
CD25, BV605-conjugated CD31 (all from Biolegend) and Live/Dead 
(red, 488 nm, Invitrogen). After washing, cells were fixed with fixa-
tion/permeabilization solution (eBioscience) for 30 minutes at room 
temperature in the dark. Cells were washed with permeabilization 
buffer (eBioscience). Following centrifugation and re-suspension in 
MACS buffer, AF647-conjugated FoxP3 (Biolegend) antibodies were 
added for 30 minutes in the dark. Cells were then washed and run 
on an LSRII flow cytometer equipped with blue, red and violet lasers 
(BD Biosciences). At least 50,000 cells were recorded per sample. 
Unstained and single-stained samples were used as compensation 
controls in flow cytometry experiments. All antibodies and dyes were 
used in concentrations recommended by the relevant manufacturer.
In both panels during the gating process, doublets were first 
excluded based on FSC-A and FSC-H characteristics. Lymphocytes 
were then identified based on FSC-A and SSC-A characteristics. 
Dead, as well as CD14+, CD19+ and CD56+ cells were excluded 
based on positivity in the ECD channel. Further gating was per-
formed within CD3+ cells (Supplementary Figure 1). Flow cytometry 
data were analysed using the FlowJo software package.
2.3  |  T cell proliferation using mixed lymphocyte 
reaction assay
Mononuclear cells were prepared as described above. Stimulator cells 
were extracted and re-suspended in enriched media for irradiation. 
Cells were irradiated at 3000 rad. For responder cells, T-cell enrich-
ment was performed using the Easy Sep T cell enrichment antibody 
mix (1 μL per 106 cells), magnetic beads and Easy Sep Purple Magnet 
separation (Stemcell Technologies) as described earlier.19 Mixed lym-
phocyte reactions (MLRs) were applied in the following combina-
tions: maternal T-cell responders vs irradiated cord blood cells, cord 
blood T-cell responders vs irradiated maternal cells, maternal T-cell 
responders vs irradiated neonatal cells and neonatal T-cell respond-
ers vs irradiated maternal cells. For the set-up of neonatal MLRs, all 
corresponding maternal cells had undergone prior cryopreservation 
and were thawed as described above. In selected maternal, cord 
blood and neonatal samples (n = 6 each), the T cell-enriched suspen-
sions were split between non-CD25-depleted and CD25-depleted 
samples. Suspensions that were retained for CD25 depletion were 
depleted using CD25 MicroBeads with magnetic MACS microcolumn 
separation (Miltenyi Biotec, Bergisch Gladbach, Germany).
To trace proliferation of responder T cells in the assay, 1 μL of 
CellTrace Violet dye (Invitrogen) was added per 106 cells and in-
cubated at 37 degrees for 20 minutes. 2 x 105 irradiated stimulator 
mononuclear cells were added at a 2:1 ratio to each responder sample 
of 1 x 105 in a 96-well round-bottom plate in enriched media. Each 
sample was run in duplicate. Positive control samples were estab-
lished with the addition of 5 μL of CD3/CD28 activator Dynabeads 
(Thermo Fisher Scientific, Waltham, MA, USA) instead of stimulator 
cells. Negative controls were established in enriched media only. To 
each sample and positive control, 10 U of IL-2 cytokine was added. 
Samples were incubated for 5 days. At day 3, 150 μL of media per 
well was replaced with fresh media. Each sample was harvested and 
washed with phosphate-buffered saline (PBS) (Sigma-Aldrich). Surface 
staining was performed in MACS buffer using APC-Cy7-conjugated 
CD3, BV510-conjugated CD4 and PerCP-Cy5.5-conjugated CD8 (all 
from Biolegend). Samples were washed and then re-suspended. 1 
μL of propidium iodide (Biolegend) was added for live/dead discrim-
ination to each sample immediately before flow cytometry was per-
formed on an LSRII flow cytometer equipped with blue, red and violet 
lasers (BD Biosciences). At least 20,000 cells were recorded per sam-
ple. Unstained and single-stained samples were used as compensation 
controls in flow cytometry experiments. All antibodies and dyes were 
used in concentrations recommended by the relevant manufacturer.
During the gating process, doublets were first excluded based 
on FSC-A and FSC-H characteristics. Lymphocytes were then iden-
tified based on FSC-A and SSC-A characteristics. Dead cells were 
excluded based on positivity in the ECD channel. Further gating was 
performed within CD3+ cells (Supplementary Figure 1). Flow cytom-
etry data were analysed using the FlowJo software package.
2.4  |  Cytokine production
MLRs were applied in the combinations as described above. On day 
5, supernatants from each well (100 μL) of selected samples (n = 13) 
were collected and frozen. The concentration of cytokines in each 
supernatant sample was analysed in batches after thawing using a 
custom designed Luminex plate as per the manufacturer's instruc-
tions (Bio-Techne, Minneapolis, MI, USA). The concentration of 
IFN-γ, IL-4, IL-6, IL-8, IL-10, IL-17 and TNF-α were analysed using a 
Bio-Plex 200 plate reader and the Bio-Plex Manager 6.1 software 
(Bio-Rad, Hercules, CA, USA).
2.5  |  Stool DNA extraction, 
amplification and sequencing
2.5.1  |  Neonatal stool collection
Whole nappies were removed by the parents and placed into a trans-
port bag. Samples were then taken from the nappies by a gloved 
study personnel using a sterile scoop and then placed into sterile 
glass containers. Stool samples were frozen immediately and stored 
at −20 degrees until DNA extraction.
2.5.2  |  Extraction of neonatal stool DNA
DNA was extracted from thawed stool samples using the QIAamp 
Fast DNA Stool Mini Kit (Qiagen, Hilden, Germany). For all extrac-
tions, 290–310 mg of stool was transferred into Lysing Matrix E 
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2 mL tubes (MP Biomedicals, Illkirch-Graffenstaden, France). Tubes 
without stool were used as negative controls for each batch of sam-
ples. Samples underwent 4 cycles of bead beating for 30 seconds 
using the FastPrep-24 5G Instrument (MP Biomedicals). The sus-
pensions were heated to 95 degrees for 5 minutes and then centri-
fuged (2 minutes, 12000 rpm). The remaining extraction steps were 
performed according to the manufacturer's instructions. DNA was 
eluted using 100 μL of elution buffer and samples were centrifuged 
for 2 minutes to elute the DNA. DNA yield was assessed using the 
Qubit dsDNA HS Assay kit with a Qubit 2.0 fluorometer (Invitrogen). 
Extracted DNA was stored at −80 degrees until amplified.
2.5.3  |  Amplification of bacterial DNA
16S rRNA genes were amplified with primers targeting the V4 region 
using the standardized Earth Microbiome 16S Illumina Amplicon pro-
tocol.20 Samples were processed in batches with appropriate negative 
controls to ensure there were no contaminants arising from the DNA 
extraction kits as described earlier.21 Following clean-up, the amplicon 
fragment lengths were assessed for quality using Tapestation (Agilent, 
Santa Clara, CA, USA). DNA was quantified for each amplicon using the 
Qubit dsDNA HS Assay kit with a Qubit 4.0 fluorometer (Invitrogen). 
Each DNA library was normalized to a DNA concentration of 4 nM and 
then pooled to contain 5 μL DNA from each sample. The quality of the 
pooled DNA sample was assessed on Tapestation and demonstrated an 
average base pair length of 401 bp. Using the Qubit method described 
above, the pooled DNA was quantified to an average 1.61 ng/μL.
2.5.4  |  Sequencing and Identification of 
bacterial DNA
The pool of stool DNA was sequenced in one sequencing run. 
Sequences were obtained using an Illumina MiSeq paired-end 250-
bp protocol for 500 cycles. The PCR was performed in one batch 
with appropriate negative controls following which paired-end se-
quencing (2 × 250 bp) was performed on the Illumina MiSeq platform 
(Illumina, San Diego, CA, US) and processed using the Quantitative 
Insights Into Microbial Ecology 2 (QIIME2) pipeline.22 Samples were 
rarefied prior to alpha and beta diversity analysis. Taxonomy as-
signment was done against the Silva-132–99% OTUs database and 
differences in relative abundance of taxa between cohorts were 
analysed using linear discriminant analysis (LDA) effect size (LEfSe). 
Taxa with LDA >2 at a p value <0.05 were considered significant.
2.6  |  Univariate statistical modelling
2.6.1  |  Statistical analysis
Comparisons were made using the Kruskal-Wallis test or the Mann-
Whitney U test as the distribution of data appeared to be non-normal 
according to the Shapiro-Wilk test. p values <0.05 were consid-
ered significant. Data are presented as median [interquartile range]. 
Statistics were calculated using the GraphPad Prism 5 and 8 software.
2.6.2  |  Random Forest machine learning method
We used Random Forest (RF) for data integration and individual data 
set analysis. RF is a machine learning ensemble method in conjunc-
tion with multiple learning algorithms to obtain better predictive per-
formance.23 RF can be used for both classification and regression. In 
our analysis, we used RF for classification using the feeding method 
(exclusively breastfed vs exclusively formula-fed) as outcome variable 
and treating each of the data sets separately. We used ntree =500 
and mtry =square root of variables in our models. We used two pack-
ages for RF analysis (randomForest and varSelRF) in R (v3.6.1).
2.6.3  |  The Backward elimination method
To select features automatically, we iteratively fitted random for-
ests, at each iteration building a new forest after discarding 20% of 
the features with the smallest variable importance. The selected set 
of features was used as a predictor to fit the model to check the ‘out 
of bag’ (OOB) error rate. We examined the OOB error rates from 
all fitted random forests. We chose the solution with the smallest 
number of variables whose error rate was within one standard error. 
This procedure was performed iteratively using the varSelRF pack-
age in R (v3.6.1).
2.6.4  |  Network analysis
We used the qgraph package in R (v3.6.1) to perform network analy-
sis. A network is a set of nodes and a set of edges, where each node 
represents either an immune parameter or an operational taxonomic 
unit (OTU) from microbiome analysis whereas the edges represent 
associations amongst them. Pearson correlation coefficients were 
used to quantify the strength of associations between combinations 
of immune parameters or OTUs.
3  |  RESULTS
3.1  |  Neonates develop both protective and 
tolerogenic adaptive immune responses in the first 
three weeks of life
The proportion of CD3+ cells was lower in cord blood compared 
with maternal blood, whilst that of CD4+ cells was nearly twofold 
higher. CD8+ cell percentages both at birth and at 3 weeks of age 
were nearly half of those seen in maternal and non-pregnant adult 
samples (Figure 1a).
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The proportion of CD4+ FoxP3+ CD25hi Tregs increased from 
6.4% in cord blood to 8.0% within the first 3 weeks of life, compa-
rable to the level in non-pregnant adults but remained lower than 
third trimester maternal samples (Figure 1b). Interestingly, within the 
different feeding groups at 3 weeks of age, the frequency of Tregs 
was nearly twofold higher (9.3% vs 4.9%) in exclusively breastfed 
compared with exclusively formula-fed neonates (Figure 1c&d). We 
also examined the expression of selected cell surface markers on 
Treg cells at birth and at 3 weeks of age. HLA-DR expression in-
creased during the first 3 weeks of life, potentially reflecting recent 
activation; however, no difference was detected in the expression of 
CD45RA, CD31 or CD69 between the two time points (Figure 1e). 
Of note, no difference was observed in the expression of these 
markers between the different feeding groups.
We then went on to determine the functional activity of T cells 
through analysis of intracellular cytokine and surface CD107a expression, 
a marker of degranulation in response to mitogenic stimulation. The pro-
portion of IL-8+ CD4+ cells was lower, whereas that of IFN-γ+ CD4+ cells 
was higher in maternal compared with neonatal samples (Supplementary 
Figure 2). No differences were observed in the profile of IFN-γ, IL-4, IL-6 
or IL-8 expression by CD4+ and CD8+ cells between birth and 3 weeks of 
age. However, the number of IL-17+ CD8+ cells, as well as the mean fluo-
rescence intensity of IL-17 in CD4+ and CD8+ cells, increased during the 
first three weeks (Figure 2a and Supplementary Figure 3). Interestingly, 
at 3 weeks of age the mean fluorescence intensity of IFN-γ in CD4+ and 
CD8+ cells was nearly three times higher in exclusively formula-fed neo-
nates compared with those receiving breast milk (Figure 2b). No further 
differences were observed between feeding groups.
A higher proportion of CD8+ cells expressed CD107a, a marker 
of cytotoxic degranulation, in non-pregnant adult samples com-
pared with neonatal samples at birth and 3 weeks of age. The 
mean fluorescence intensity of CD107a expression on CD8+ cells 
F I G U R E  1  Alterations of T-cell subsets and the regulatory T-cell (Treg) phenotype in neonates between birth and 3 weeks of age. A, 
The frequency of CD3+, CD4+ and CD8+ cells in neonatal blood samples (n = 17) at birth and at 3 weeks of age, as well as in maternal 
blood (n = 17) and healthy controls (n = 8). B, The frequency of CD4+ FoxP3+ CD25hi cells in neonatal blood samples (n = 19) at birth and 
at 3 weeks of age, as well as in maternal blood (n = 19) and healthy controls (n = 13). C, The frequency of CD4+ FoxP3+ CD25hi cells in 
neonatal blood samples at 3 weeks of age grouped according to the feeding method: exclusively breastfed (n = 9), mixed feeding (n = 5) 
and formula-fed (n = 5) neonates. D, Representative dot plots of CD4+ FoxP3+ CD25hi cells in a breastfed and a formula-fed neonate at 
3 weeks of age, gated within CD4+ cells. E, The expression of selected cell surface markers on Tregs in neonatal blood samples at birth and 
at 3 weeks of age (n = 19). Horizontal lines represent medians and interquartile ranges. * p < 0.05, ** p < 0.01, *** p < 0.001.
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was higher in adult compared with neonatal samples (Figure 2c and 
Supplementary Figure 4). No differences were observed between 
feeding groups.
3.2  |  T cells of exclusively breastfed neonates 
show reduced proliferation in response to stimulation 
by maternal cells
We performed MLRs on blood samples of 37 mother-and-baby 
dyads. Initially, maternal cells were stimulated with irradiated cord 
or neonatal cells and here we observed increased proliferation of 
CD3+ and CD4+ cells in response to neonatal PBMCs at 3 weeks 
of age compared with birth (Supplementary Figure 5a). A similar 
increase (CD3+: 5.4 vs 15.5% median proliferating cells, CD4+: 5.3 
vs 18% median proliferating cells) was observed when responder 
T cells of a non-pregnant healthy adult were used in combination 
with neonatal stimulator cells (Supplementary Figure 5b).
We next utilized cord and neonatal T cells in MLRs against irradi-
ated maternal PBMCs (Figure 3a). The rate of proliferation on Figure 3a 
is represented by the proportion of cells with a lower concentration of 
the CellTrace Violet dye, signifying the dilution of the dye in prolifer-
ating cells. Interestingly, here we observed decreased proliferation in 
neonatal CD3+ and CD8+, but not CD4+ cells in response to maternal 
stimulator cells at 3 weeks of age compared with birth (Figure 3b).
We further examined the influence of neonatal nutrition on these 
proliferative responses at 3 weeks of age. Sixteen neonates had been 
exclusively breastfed whereas 13 had received only formula and 8 
F I G U R E  2  Alterations of the 
pro-inflammatory and cytotoxic 
immunophenotype in neonates 
between birth and 3 weeks of age. A, 
The intracellular frequency and mean 
fluorescence intensity (MFI) of selected 
pro-inflammatory cytokines in CD4+ 
cells in neonatal blood samples at birth 
and at 3 weeks of age (n = 17). B, The 
intracellular frequency and MFI of 
interferon gamma (IFN-γ) in CD4+ cells in 
neonatal blood samples at 3 weeks of age 
grouped according to the feeding method: 
exclusively breastfed (n = 8), mixed 
feeding (n = 5) and formula-fed (n = 4) 
neonates. C, The frequency of CD8+ and 
CD8+ CD107a+ cells and MFI of CD107a 
in CD8+ cells in neonatal blood samples 
(n = 17) at birth and at 3 weeks of age, as 
well as in maternal blood samples (n = 17) 
and healthy controls (n = 8). Horizontal 
lines represent medians and interquartile 
ranges. * p < 0.05, ** p < 0.01, *** 
p < 0.001.
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had undergone a mixed milk intake. The decrease in the proliferation 
rate of CD3+ cells was still evident in exclusively breastfed neonates 
(60.7 vs 28.9% median proliferating cells) but was not present in the 
mixed feeding and exclusively formula-fed groups (Figure 3c). The 
same pattern was observed in CD4+ and CD8+ cells. Interestingly, 
the proliferation rate of CD3+, CD4+ and CD8+ cells of exclusively 
breastfed neonates was comparable at birth and at 3 weeks of age 
when PBMCs of a non-pregnant healthy adult were used as stim-
ulators (n = 6), reflecting that the neonatal tolerance is specific to 
maternal antigens.
3.3  |  Neonatal immune tolerance promoted 
by breastfeeding is mediated by regulatory T 
cells and is associated with a reduction in release of 
inflammatory cytokines
Having observed that breastfeeding promotes the expansion of Tregs 
and suppresses proliferative responses against maternal antigen, we 
next investigated whether this immune tolerance was dependent on 
the presence of Tregs. To this end, we repeated the MLRs on a set 
of 6 mother-and-baby dyads where babies were exclusively breastfed 
F I G U R E  3  Neonatal T-cell response upon maternal antigen stimulation. A, Representative sample of a mixed lymphocyte reaction 
(MLR) at birth and at 3 weeks of age with negative and positive controls. Positive controls were established with the addition of CD3/CD28 
activator beads instead of stimulator cells. Negative controls were established in enriched media only. Samples were incubated for 5 days. B, 
Percentage of neonatal proliferating T cells (n = 37) at birth and at 3 weeks of age in response to maternal irradiated cells in the CD3+, CD4+ 
and CD8+ cell subsets. C, Percentage of neonatal proliferating CD3+ cells at birth and at 3 weeks of age in response to maternal irradiated 
cells grouped according to the feeding method: exclusively breastfed (n = 16), mixed feeding (n = 8) and formula-fed (n = 13) neonates. 
Horizontal lines represent medians and interquartile ranges. * p < 0.05, ** p < 0.01.
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following the depletion of CD25+ cells (Figure 4a). Pregnancy is asso-
ciated with peripheral accumulation of Tregs and the proliferation of 
maternal CD3+ cells in response to neonatal antigens increased both 
at birth (20.4 vs 59.7% median proliferating cells) and at 3 weeks of 
age (34.1 vs 57.1% median proliferating cells) following depletion of 
CD25+ cells (Figure 4b). The same pattern was observed for CD4+ but 
not in CD8+ cells. Of note, the proliferation of neonatal CD3+ cells 
in response to maternal antigens increased after depletion of CD25+ 
cells in samples taken at 3 weeks of age (71.4 vs 85.1% median pro-
liferating cells) but this was not seen with the use of cord blood cells 
(Figure 4c). The same pattern was observed for CD4+ but not in CD8+ 
cells.
We also measured the concentration of cytokines in MLR super-
natants (n = 11) produced by neonatal T cells of exclusively breast-
fed neonates in response to maternal antigens. The concentration of 
IFN-γ and TNF-α was found to be lower at 3 weeks of age compared 
with birth, whereas no difference was observed in case of the other 
cytokines tested (IL-4, IL-6, IL-8, IL-10, IL-17). The maximal IFN-γ and 
TNF-α producing capacity of neonatal T cells, tested by culturing with 
CD3/CD28 activator beads, was higher both at birth and at 3 weeks 
of age compared with the level seen in response to maternal antigens 
at 3 weeks (Figure 4d). As such, breastfeeding is seen to suppress the 
inflammatory Th1 cytokine response of neonatal T cells in response to 
maternal antigen stimulation.
3.4  |  Breastfeeding has modest impact on the gut 
microbiome in neonates born by caesarean section 
within the first 3 weeks of life
To evaluate the impact of breastfeeding on the neonatal gut mi-
crobiome, we analysed stool samples from exclusively breastfed 
and exclusively formula-fed neonates collected at 3 weeks of age. 
Meconium samples had also been collected at birth but the amount 
of DNA extracted from these samples was consistently <0.15 ng/μL. 
PCR amplification using 16S primers on these DNA samples yielded 
undetectable product for further analysis, reflecting minimal or no 
microbial colonization immediately after birth.
In the stool samples at 3 weeks of age, following microbial 16S 
rRNA gene amplification, a median frequency of 18,354 amplicon 
F I G U R E  4  Maternal and neonatal T-cell response in mixed lymphocyte reactions (MLR) following the depletion of CD25+ cells and 
pro-inflammatory cytokine production by neonatal T cells in exclusively breastfed neonates in MLR upon maternal antigen stimulation at 
birth and at 3 weeks of age. A, Representative dot plots with and without the depletion of CD25+ cells in a neonatal sample at 3 weeks of 
age, gated within CD3+ cells. CD25+ cells were depleted using magnetic microbead separation. B, Percentage of maternal proliferating T 
cells (n = 6) in response to neonatal stimulator cells of exclusively breastfed neonates from birth and 3 weeks of age in the CD3+ subset. C, 
Percentage of neonatal proliferating T cells (n = 6) in response to maternal stimulator cells at birth and at 3 weeks of age in the CD3+ subset 
of exclusively breastfed neonates. D, The concentration of IFN-γ and TNF-α was found to be lower at 3 weeks of age compared with birth 
(n = 11). The maximal IFN-γ and TNF-α producing capacity of neonatal T cells was also assessed at birth and at 3 weeks of age by culturing 
them with CD3/CD28 activator beads. The production of IFN-γ and TNF-α was higher both at birth and at 3 weeks of age compared with 
the level seen in response to maternal antigens at 3 weeks. Horizontal lines represent medians and interquartile ranges. * p < 0.05, ** 
p < 0.01, *** p < 0.001.
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sequence variants (ASV) per sample were retained after trimming 
and filtering. The composition of gut microbiota from exclusively 
breastfed and exclusively formula-fed neonates was broadly similar, 
and no differences in any alpha or beta diversity metrics were seen 
(Figure 5a). Principal component analysis (PCA) of gut microbiota 
composition of exclusively breastfed and exclusively formula-fed 
neonates demonstrated that individuals in these groups cluster 
closely together, and breastfeeding is associated with the presence 
of Gemella (Figure 5b). Linear discriminant analysis (LDA) effect size 
(LEfSe) revealed enrichment of the Veillonella and Gemella taxa in 
exclusively breastfed neonates (Figure 5c). Random forest (RF) anal-
ysis identified the presence of Staphylococcus, followed by that of 
Gemella to be the most significant parameters distinguishing the two 
groups of exclusively breastfed and exclusively formula-fed neo-
nates (Figure 5d).
3.5  |  Network modelling links Veillonella 
to regulatory T-cell expansion whilst skin-
associated bacteria enhance T-cell proliferation in 
breastfed neonates
Finally, we undertook an integrative analysis of the combined data 
from flow cytometry, MLR and microbiome sequencing of neonates 
at 3 weeks of age. Network modelling revealed a range of positive 
and negative correlations between these parameters. In breastfed 
neonates, CD4+ and CD8+ proliferative responses against maternal 
antigen were strongly correlated with Gemella and skin-associated 
taxa (Figure 6a). The presence of Veillonella within the microbiome 
correlated with the prevalence of Tregs at 3 weeks, and this ef-
fect was independent of nutrition history (Figure 6b). In breastfed 
neonates, Veillonella was also associated with HLA-DR expression 
on CD4+ cells and IFN-γ production in CD8+ cells. These findings 
suggest that Veillonella may act to enhance regulatory responses in 
the early period of life whereas skin-associated bacteria, potentially 
acquired through breastfeeding, may act to promote proliferative 
responses.
4  |  DISCUSSION
The influence of early life nutrition on the development of the im-
mune response has not previously been studied in the first few 
weeks of life. This is an important question as epidemiological data 
suggest that breastfeeding is associated with long-term health 
benefits, such as a lower incidence of childhood infections, asthma, 
obesity and autoimmune disorders,24-26 although it may not reduce 
the risk of food allergy.27 This mechanism may be imprinted early 
after birth when the immune system faces the dual challenge of es-
tablishing inflammatory capacity against pathogens whilst develop-
ing tolerance towards harmless antigens.
A striking finding was that Tregs expand substantially in the first 
3 weeks of life and this expansion was more profound in breastfed 
babies in contrast to those receiving formula feed. Tregs of breast-
fed neonates also display an activated phenotype with increased 
expression of HLA-DR, a marker of increased suppressive activity.28 
A recent mouse study on the role of maternal milk in setting the 
frequency of Tregs in the offspring reported the importance of a 
double-negative feedback loop, vertically transmitted via the en-
teromammary axis that governs a set point for Tregs in the gut.29 
On the other hand, changes in the profile of pro-inflammatory cy-
tokine production were also observed at this early stage of life. IL-8 
production, a major phenotypic attribute within cord blood, was 
largely maintained but a striking feature was the increase in inten-
sity of IL-17 production by both CD4+ and CD8+ cells by 3 weeks of 
age. This is likely to reflect recognition of bacterial antigen during 
establishment of the microbiome and may be balanced by the co-
ordinated Treg expansion during this period. An increase in serum 
IL-17 has been shown at 4 weeks and is likely explained by these 
observations.7 Most of these features were independent of nutri-
tion although IFN-γ production by T cells was lower in exclusively 
breastfed neonates. However, in the whole study population, we 
did not observe any difference in the proportion of Th1 and Th2 
cells between birth and 3 weeks of age. Earlier studies indicated 
that Th1 development may be guided by environmental exposure 
via epigenetic changes and would therefore be expected to occur 
at later stages (first months to years) of development. Low micro-
bial exposure during early life was reported to increase the risk of 
allergic disease by reducing demethylation induced activation of the 
IFN-γ gene of naive T cells.30 Our observation that CD8+ cells are 
less abundant and have reduced cytotoxic capacity in neonates com-
pared with adults confirms previous results.31,32
One of the most interesting findings was that T cells from breast-
fed neonates display reduced proliferative responses and produce 
substantially lower levels of Th1 cytokines when challenged with 
maternal cells. This was specific to maternal antigens and was not 
present against unrelated PBMC and did not result from an intrin-
sic reduction of cytokine producing capacity. As such, this reflects 
the development of immunological tolerance against non-inher-
ited maternal antigens (NIMA) in exclusively breastfed neonates. 
F I G U R E  5  Microbiome analysis of neonatal stool samples at 3 weeks of age in exclusively breastfed (n = 9) and exclusively formula-fed 
(n = 12) neonates. A, Relative frequency of bacterial phyla in the two cohorts. B, Principal component analysis (PCA) of gut microbiota 
composition of exclusively breastfed (red) and exclusively formula-fed (blue) neonates at 3 weeks of age determined by bacterial 16S rRNA 
amplification. Numbers represent the individual study number of each participant. Pooled variables of milk received are represented by the 
large red circle for breast milk and the large blue triangle for formula, respectively. C, Association of specific microbial taxa with the feeding 
method by linear discriminant analysis (LDA) effect size (LEfSe). Red indicates taxa enriched in exclusively breastfed neonates. D, Ranking of 
gut microbial strains using the random forest (RF) method in exclusively breastfed (BM) and exclusively formula-fed neonates at 3 weeks of 
age.
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Importantly, we were also able to show that NIMA-specific toler-
ance was mediated by Tregs and is therefore linked to the expansion 
of this population in breastfed neonates.
An additional observation was that neonatal PBMC at 3 weeks 
of age triggered stronger immune responses from maternal PBMC 
compared with cord blood cells. This may reflect maturation of an-
tigen presentation function by 3 weeks of age, although this was 
not assessed in this study. This also indicates that the foetal immune 
system may contribute to suppression of maternal immune recogni-
tion during pregnancy by maintaining a tolerogenic phenotype prior 
to parturition.
It is interesting to speculate on potential mechanisms by which 
breastfeeding can promote NIMA-specific tolerance in neonates. 
Our observations likely reflect immune tolerance to gastrointestinal 
presentation of maternal cells within breast milk.33 Transplacental 
passage of cells during pregnancy leads to reciprocal microchime-
rism that can persist for many years. Furthermore, this ‘microchiome’ 
of maternal cells supports fertility in female offspring by promoting 
immune tolerance to NIMA during next-generation pregnancies.34 
Beneficial effects are also seen when NIMA are shared between 
donors and recipients of allogeneic renal or hemopoietic stem cell 
transplantation. Importantly, the establishment of NIMA-specific 
tolerance has been shown to be dependent on breastfeeding and 
nutritional history is also a determinant of NIMA-associated trans-
plant outcome.35,36 Our findings show that breastfeeding promotes 
the development of Tregs that suppress recognition of NIMA, thus 
potentially supporting maternal microchimerism and conferring life-
long benefits in relation to fertility and immune protection against 
infectious agents and cancer.34,37
Additionally, recent studies highlighted the possible immune 
modulating effects of microplastics released from feeding bottles, 
which may be of relevance in the context of our study.38,39 However, 
the possible contribution of the above mechanism to the differences 
observed between our study groups was not assessed.
A further recent observation is that breastfeeding, through the 
transfer of human milk oligosaccharides, exerts important prebi-
otic and immunomodulatory effects including the development of 
tolerogenic dendritic cells which prime Tregs.40,41
We were also interested to assess how nutrition could impact 
on the formation of the early microbiome and how this might cor-
relate with immune function. Microbial composition was broadly 
comparable in breastfed and formula-fed neonates, and this is 
F I G U R E  6  Integrated analysis of 
mixed lymphocyte reaction (MLR), flow 
cytometry and microbiome data of 
A, exclusively breastfed (n = 9) and B, 
exclusively formula-fed (n = 5) neonates 
at 3 weeks of age. Various positive 
and negative correlations between the 
studied parameters were revealed. Green 
represents a positive correlation, whereas 
red represents a negative correlation. 
Thicker lines represent stronger 
correlations. Nodes in blue represent MLR 
data, nodes in black represent microbiome 
data, and nodes in purple and orange 
represent flow cytometry data from 
the panels with and without mitogenic 
stimulation, respectively.
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likely to reflect the fact that all babies in our cohort were deliv-
ered by caesarean section. Dysbiosis of the microbiota has been 
found to occur following delivery by caesarean section and in in-
fants who are not breastfed.42,43 Nevertheless, although it may 
take several months for nutrition to markedly influence microbi-
ome composition44 subtle differences in microbial diversity were 
already apparent at 3 weeks of life. In line with previously pub-
lished results,45 we observed that the gut microbiome of breastfed 
neonates is more abundant in short chain fatty acid (SCFA) pro-
ducing bacterial genera, such as Gemella and Veillonella. SCFAs, in 
particular propionate and butyrate, play an important role in pro-
moting Treg differentiation and proliferation via the inhibition of 
histone deacetylases.12 This notion is supported by a link between 
the presence of Veillonella and the proportion of Tregs at 3 weeks 
of age in our network modelling analysis. Furthermore, a recent 
study demonstrated paucity of Veillonella and other anaerobic 
taxa in the microbiome of extremely preterm infants with post-
natal growth failure compared with appropriate postnatal growth, 
indicating its role in early metabolic programming.46 The relative 
abundance of Veillonella further increases by 2 months of age.47
We selected elective caesarean deliveries for our study as labour 
is known to promote pro-inflammatory changes,48,49 which could have 
introduced unwanted variation in the study immune parameters in 
our population depending on the length and characteristics of labour 
and parturition. Further studies will therefore be needed to establish 
the relative contribution of mode of delivery and nutritional history 
to the development of NIMA-specific tolerance in the neonate. The 
applied method of collecting stool samples from nappies is limited by 
possible contamination with environmental and skin bacteria, which 
was taken into account during the analysis of microbiome data. A fur-
ther limitation of this work is the relatively low number of neonates in 
the examined feeding groups. Nevertheless, we established a unique 
and homogenous cohort of healthy neonates who were sampled at 
3 weeks of age exclusively for the purposes of this study.
In summary, we demonstrate that the neonatal immune system 
undergoes substantial maturation in the first 3 weeks of life with an 
increase in IL-17 production in T cells and a simultaneous increase 
in the Treg population. Moreover, breastfed neonates show a spe-
cific and Treg-dependent reduction in proliferative T-cell responses 
to NIMA, associated with a reduction in inflammatory cytokine 
production. These findings add to our understanding of mecha-
nisms by which early life nutrition can determine long-term health 
outcomes.50
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